Navigation Links
Two DEMO alumni make big product splashes
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Two DEMO alumni make big product splashes

(Date:7/28/2015)... , ... July 28, 2015 , ... VetStem Biopharma will ... stem cell credentialing course to local area veterinarians. , The tour and course will ... units at no charge) at VetStem’s Poway facility. Staff members are welcome to attend ...
(Date:7/28/2015)... 2015 BioStructures, LLC, a privately held ... milestone of 4,000 implantations of Signafuse® Bioactive Bone ... early 2014 as a bone void filler indicated ... This is a distinguished status among recently cleared ... new synthetic products have received clearance with a ...
(Date:7/28/2015)... July 28, 2015  Faced with increasing challenges ... palliative rather than symptomatic, the global healthcare industry ... therapies capable of curing or significantly changing the ... to look towards regenerative medicine as a viable ... paradigm in human health with the potential to ...
(Date:7/27/2015)... ... ... Production of high tenacity filament yarn of viscose rayon (excluding sewing thread) ... it surpassed the EUR 106 million mark (in value terms) in 2013, while it ... producer, while Italy is a key consumer. , The high tenacity filament yarn ...
Breaking Biology Technology:VetStem Biopharma weekly veterinary continuing education classes and GMP manufacturing facility tour 2Revolutionary Bone Graft Exceeds Expectations 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 4Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 5High Tenacity Filament Yarn of Viscose Rayon Consumption to Grow Swiftly in the EU, Forecasts BAC Reports in New Study Available at MarketPublishers.com 2
... data available by spring 2009 to support, the ... -, ROCKVILLE, Md., Nov. 1 Human Genome ... has completed enrollment and,initial dosing ahead of schedule in ... trials of Albuferon(R) (albinterferon alfa-2b) in,combination with ribavirin in ...
... Shares Her Personal Story and Tips for Better Blood ... ... more,than 20 million Americans living with diabetes, Emmy nominated actress and,Broadway star ... to urge other Americans with diabetes to reach,better levels of blood sugar ...
... schedule ... -, - Progress continues on LymphoStat-B, ABthrax and TRAIL receptor antibody ... programs - ... 1 Human Genome Sciences,Inc. (Nasdaq: HGSI ) today announced financial results and key developments,for the ...
Cached Biology Technology:Human Genome Sciences Completes Enrollment Ahead of Schedule in Second Phase 3 Albuferon(R) Trial 2Human Genome Sciences Completes Enrollment Ahead of Schedule in Second Phase 3 Albuferon(R) Trial 3Human Genome Sciences Completes Enrollment Ahead of Schedule in Second Phase 3 Albuferon(R) Trial 4Human Genome Sciences Completes Enrollment Ahead of Schedule in Second Phase 3 Albuferon(R) Trial 5Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes 2Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes 3Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes 4Human Genome Sciences Announces Third Quarter 2007 Financial Results and Key Developments 2Human Genome Sciences Announces Third Quarter 2007 Financial Results and Key Developments 3Human Genome Sciences Announces Third Quarter 2007 Financial Results and Key Developments 4Human Genome Sciences Announces Third Quarter 2007 Financial Results and Key Developments 5Human Genome Sciences Announces Third Quarter 2007 Financial Results and Key Developments 6Human Genome Sciences Announces Third Quarter 2007 Financial Results and Key Developments 7Human Genome Sciences Announces Third Quarter 2007 Financial Results and Key Developments 8Human Genome Sciences Announces Third Quarter 2007 Financial Results and Key Developments 9
(Date:7/9/2015)... Calif. , July 9, 2015  Synaptics Inc. (NASDAQ: ... solutions, announced today that it will report financial results ... Thursday, July 30, 2015 after the close of market. ... analysts and investors at 2:00 p.m. PT (5:00 p.m. ... To participate on the live call, analysts ...
(Date:7/9/2015)... , July 9, 2015  Unchained Labs just ... its acquisition of Avid Nano. Avid Nano designs, ... (DLS) systems.    Also today, Unchained ... and easiest to use protein sizing system. The ... a protein,s hydrodynamic size, size distribution, aggregation population ...
(Date:7/8/2015)... , July 8, 2015 Summary Pancreatic ... the fourth most fatal, with a mortality rate of ... prognosis of pancreatic cancer patients has highlighted a significant ... is not being met by the current market. ... of products with varying molecule types and mechanisms of ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... Detecting oral cancer in its earliest stages can save the ... detection has been difficult. Case Western Reserve University ... beta defensin-3 (hBD-3), which may serve as an early warning. ... associated with the early stages of oral cancer. ...
... Samuel Waxman Cancer Research Foundation (SWCRF) has awarded 13 ... $1.54 million. The 16 grants represent a portion of ... award more than $2 million this year to cancer ... scientific minds in differentiation therapyreprogramming cancer cellsa hallmark of ...
... UK National Stem Cell Network annual science conference today,(13 ... treating heart attack and cardiomyopathy using stem cells. ... London, said "Recent clinical trials using stem cells to ... safety but unfortunately the bone marrow stem cells used ...
Cached Biology News:CWRU dental researchers discover human beta defensins-3 ignite in oral cancer growth 2The Samuel Waxman Cancer Research Foundation awards $1.54 million in research grants for 2010-2011 2The Samuel Waxman Cancer Research Foundation awards $1.54 million in research grants for 2010-2011 3Improving clinical use of stem cells to repair heart damage 2
...
Microlite 1+ 1x12 Strip assembled, flat bottom; the ideal vessel for low signal luminescent reactions, offering medium binding with enhanced dynamic range, extra high reflectivity and minimal cross t...
... SkanIt™ Software is the ultimate ... and data handling. There are two ... Research Edition for scientists working in ... Discovery Edition offering features needed for ...
... Recombinant Enterokinase (rEK) is a highly purified ... enterokinase, a serine protease which recognizes the ... (AspAspAspAspLys↓) and has similar enzymatic activity. Novagen&'s ... and purified to yield the highest ...
Biology Products: